MIRABEG

Beta-3 Adrenergic agent Featured

· Mirabegron 50 mg Prolonged Release Tablet

· Effectively reduces OAB episodes with proven efficacy and good tolerability

· Primarily indicated for the treatment of Over Active Bladder(OAB)

· Lower risk of urinary retention

Specifications

Technical Specifications

Key features and capabilities of this equipment.

Downloads

Access brochures, manuals, and specification sheets for this product.